Carregant...
Neoadjuvant endocrine therapy in breast cancer patients
HIGHLIGHTS: The overall response rate to neoadjuvant endocrine therapy (NET) was 54.55%. The eight patients proposed to tumour's downstage, after 9.71 months of NET, preserved their breast. In the group which achieved response, 10.28 months was the mean time to accomplish it. Even patients who...
Guardat en:
| Publicat a: | Porto Biomed J |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Faculty of Medicine of the University of Porto
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806912/ https://ncbi.nlm.nih.gov/pubmed/32258615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbj.2017.03.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|